David Mathai
Psychiatrist and Assistant Professor at The Johns Hopkins University School of Medicine
Key Impact
He is a psychiatric researcher at Johns Hopkins whose work spans psilocybin, ketamine/esketamine, and psychedelic-assisted psychotherapy, with multiple publications on experiential and therapeutic outcomes.
Background & Research
David Mathai is a psychiatrist and researcher affiliated with Johns Hopkins, where his work has focused on psychopharmacology, ketamine/esketamine, and psychedelic medicine. He has contributed to studies and reviews on psilocybin, dextromethorphan, dissociation, and psychedelic risk reduction, and has been described as serving in research and clinical roles at Johns Hopkins Bayview/Center for Psychedelic and Consciousness Research. He also appears to have ongoing clinical interests in integrated and psychedelic-informed psychiatric care.
Collaboration Network
19 collaborators· click a node to visit their profile
Full network →